ArticleFrontiers in oncology2025
Vaping, smoking and risk of early onset lung cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Vaping-related lung disease: a narrative review.Journal of thoracic disease · 2026Review
- Global trends and projections of lung cancer attributable to residential radon exposure, 1990-2050.BMC cancer · 2026Article
- Toxicity and Appeal of Flavoured E-Cigarettes and Flavour Ban Outcomes: A Narrative Review.International journal of environmental research and public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is the leading cause of cancer mortality worldwide, including young adults. While it is well known that cigarette smoking is the dominant risk factor for lung cancer, the inhalation of heated aerosolized vaping oil has now replaced cigarette smoking as the major source of nicotine among young people. We, therefore, studied the potential role of both vaping and cigarette smoking in the development of early onset lung cancer. Using a case-control study design, we compared the smoking and vaping habits of 256 young adults (< 50 years of age) diagnosed with pathologically confirmed lung cancer to that of 2,921 control subjects without cancer that were group matched by age (within 5 years), sex, race and location to the cases. The odds ratio for those who both vaped and smoked (OR = 13.8, 95% CI: 7.7-24,9) was 2.8 times higher than for smoking alone (OR = 5.0, 95% CI: 3.7-6.9). Pulmonary adenocarcinomas accounted for 72% of the early onset lung tumors among the cases, and risk estimates for this specific cell type were 3.7 times higher for those who smoked and vaped (OR = 14.8, 95% CI = 8.0-27.4) compared to those who only smoked (OR = 4.0, 95% CI = 2.9-5.6). Our findings suggest that compared to smoking alone, vaping and smoking together accelerate lung cancer risk among young people, particularly in the development of pulmonary adenocarcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.